Search results
Will Walmart Reach a Trillion-Dollar Market Cap by 2030?
The Motley Fool via AOL· 3 days agoMany of them began shopping at Walmart on a regular basis. Given Walmart's current efforts to look...
THE FRIDAY 5: Kroger Offering Weight Loss Drugs; Walmart’s Turn to Shelf Labels
Progressive Grocer· 5 days agoPG readers were interested in the opening of Buc-ee's newest and largest travel center to date in...
2 Stocks I'm Looking to Buy Even as the Market Surges
TheStreet.com· 7 days agoThe danger of a sell-the-news reaction to the Fed is now higher after the CPI report. The market is...
Dozens of CVS generic drug recalls expose link to tainted factories - The Boston Globe
The Boston Globe· 2 days agoThis potentially dangerous pattern has roots in the quality of the factories from which CVS sources...
Short Interest in Welcia Holdings Co., Ltd. (OTCMKTS:WLCGF) Expands By 53.7%
ETF DAILY NEWS· 5 days agoWelcia Holdings Co., Ltd. (OTCMKTS:WLCGF – Get Free Report) was the target of a large growth in...
Rani Therapeutics (NASDAQ:RANI) Coverage Initiated by Analysts at Rodman & Renshaw
ETF DAILY NEWS· 5 days agoRodman & Renshaw started coverage on shares of Rani Therapeutics (NASDAQ:RANI – Free Report) in a report published on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $10.00 ...
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of CVS...
Morningstar· 4 days agoNEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CVS Health Corporation ...
Ozempic is now boosting sales for smaller-sized clothes, fashion executives say
Quartz· 1 day agoIn another ripple effect on the economy, Ozempic and other weight loss drugs are boosting sales of...
Discount retail chain unveils secret weapon against store theft
TheStreet.com· 6 days agoThe discount chain is undertaking a dramatic new model to prevent the growing issue.
Equities Analysts Offer Predictions for Vistagen Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:VTGN)
ETF DAILY NEWS· 5 days agoVistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Vistagen Therapeutics ...